3ders.org Forums

Full Version: An In-Depth Look At Organovo
You're currently viewing a stripped down version of our content. View the full version with proper formatting.
We are initiating coverage of Organovo, Inc. (ONVO.PK) with an 'Outperform' rating. We believe the company's pioneering efforts into three-dimensional bioprinting have the potential to dramatically improve drug discovery and development. Organovo's bioprinter, the NovoGen MMX, is a first-in-class device capable of creating three-dimensional living tissue that can be used to model a specific disease or pathway, build complex pharmacokinetic and toxicology assays, and even potentially create human organs for transplantation or other regenerative medicine applications.

An In-Depth Look At Organovo